Cargando…
SECURE, ADVOR and REVIVED: Clinical Trials Presented at ESC 2022
In this article, three important clinical trials presented at the 2022 European Society of Cardiology Congress have been selected for a brief discussion. These are the SECURE, ADVOR and REVIVED-BCIS2 trials, all of which are investigator-initiated studies whose findings are of interest given their p...
Autor principal: | Mendieta, Guiomar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947931/ https://www.ncbi.nlm.nih.gov/pubmed/36845215 http://dx.doi.org/10.15420/ecr.2022.43 |
Ejemplares similares
-
ESC Congress 2022 Imaging Highlights
por: Puntmann, Valentina O, et al.
Publicado: (2023) -
Comment on the ESC Guidelines 2022 for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
por: Cuervo, David Calvo
Publicado: (2023) -
2021 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronisation Therapy
por: Dan, Gheorghe-Andrei
Publicado: (2021) -
The DELIVER Trial: the Beginning of the End of Ejection Fraction Tyranny
por: Bayes-Genis, Antoni
Publicado: (2022) -
Highlights of Acute Coronary Syndromes
por: Recio-Mayoral, Alejandro
Publicado: (2022)